Wenfa Y. Yu
Xinxiang, 453003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 12, 2017
MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
Journal: Clinical and experimental pharmacology & physiology
Published: August 23, 2017
MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression.
Journal: Journal of cellular biochemistry
Published: July 21, 2017
EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.
Journal: Molecular and cellular biochemistry
Published: April 07, 2017
Review of 1 000 Hz probe tone tympanogram applying to evaluate middle ear of infants
Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
Published: February 20, 2017
Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
Journal: Oncology research
Published: January 22, 2017
MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Journal: European journal of pharmacology
Published: August 21, 2016
The expression and clinical significance of MyD88 in laryngeal cancer
Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
Published: December 16, 2015
Cytotoxicity of 1-dodecyl-3-methylimidazolium bromide on HepG2 cells.
Journal: Genetics and molecular research : GMR
Published: November 05, 2015
MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Journal: Gene
Published: September 04, 2015
MicroRNA-138 regulates the balance of Th1/Th2 via targeting RUNX3 in psoriasis.
Journal: Immunology letters
Published: November 24, 2014
Last Updated: 09/26/2026